Huang Kangkang, Liang Yunlai, Ma Yating, Wu Jiahui, Luo Huidan, Yi Bin
Department of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha, China.
National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.
Front Endocrinol (Lausanne). 2022 Mar 3;13:774272. doi: 10.3389/fendo.2022.774272. eCollection 2022.
The variation and correlation among adiponectin, nesfatin-1, tumor necrosis factor α (TNF-α), and interleukin 6 (IL-6), which may be involved in the development of the decline of health into prediabetes and diabetes, have not been elucidated. This study aims to investigate the roles of these cytokines in this process.
Seventy-two type 2 diabetes mellitus (T2DM) patients, 75 prediabetics, and 72 healthy individuals were enrolled in our case control study. Serum adiponectin, nesfatin-1, TNF-α, and IL-6 were tested with appropriate kits, and primary data were analyzed with correct methods.
Serum levels of each cytokine in patients with prediabetes were between T2DM and the healthy, and significant differences were found among them. TNF-α and nesfatin-1 levels in T2DM were obviously different compared to prediabetes or the healthy; IL-6 and adiponectin levels in the healthy group were significantly changed in contrast to prediabetes or T2DM. Correlation analysis found that in prediabetics, adiponectin was positively correlated with TNF-α (R = 0.2939, = 0.0105) and IL-6 (R = 0.3918, = 0.0005), and their relationship was greatly strengthened in prediabetes accompanied by insulin resistance (TNF-α: R = 0.7732, < 0.0001, IL-6: R = 0.6663, = 0.0005). We also demonstrated that declined adiponectin (OR = 6.238, = 0.019) and nesfatin-1 (OR = 2.812, = 0.01) and elevated TNF-α (OR = 5.541, = 0.001) were risk factors for prediabetes toward diabetes.
This research proved significant variations of adiponectin, nesfatin-1, IL-6, and TNF-α levels in the healthy, prediabetics, and T2DM, suggesting a slow and gradual change during the progression from a healthy condition toward diabetes prediabetes.
脂联素、促食欲素-1、肿瘤坏死因子α(TNF-α)和白细胞介素6(IL-6)之间的变化及相关性可能与健康状况下降发展为糖尿病前期和糖尿病有关,但尚未阐明。本研究旨在探讨这些细胞因子在此过程中的作用。
72例2型糖尿病(T2DM)患者、75例糖尿病前期患者和72例健康个体纳入我们的病例对照研究。使用合适的试剂盒检测血清脂联素、促食欲素-1、TNF-α和IL-6,并采用正确的方法分析原始数据。
糖尿病前期患者各细胞因子的血清水平介于T2DM患者和健康个体之间,且三者之间存在显著差异。与糖尿病前期患者或健康个体相比,T2DM患者的TNF-α和促食欲素-1水平明显不同;与糖尿病前期患者或T2DM患者相比,健康组的IL-6和脂联素水平有显著变化。相关性分析发现,在糖尿病前期患者中,脂联素与TNF-α(R = 0.2939,P = 0.0105)和IL-6(R = 0.3918,P = 0.0005)呈正相关,在伴有胰岛素抵抗的糖尿病前期患者中它们之间的关系显著增强(TNF-α:R = 0.7732,P < 0.0001,IL-6:R = 0.6663,P = 0.0005)。我们还证明,脂联素降低(比值比[OR]=6.238,P = 0.019)、促食欲素-1降低(OR = 2.812,P = 0.01)和TNF-α升高(OR = 5.541,P = 0.001)是糖尿病前期发展为糖尿病的危险因素。
本研究证实了健康个体、糖尿病前期患者和T2DM患者脂联素、促食欲素-1、IL-6和TNF-α水平存在显著差异,提示从健康状态发展为糖尿病前期的过程中存在缓慢而渐进的变化。